Top Markets
Coin of the day
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)

Xvivo Perfusion AB (publ)

XVIVO
Clasificación en acciones #9727
Xvivo Perfusion AB (publ) is a medical technology company that creates and... Xvivo Perfusion AB (publ) is a medical technology company that creates and supplies advanced solutions for the preservation and perfusion of organs, tissues, and cells, primarily for use in transplantation. The company's global reach extends across Sweden, the United States, both North and South America, Europe, the Middle East, Africa, and the Asia Pacific region. Its product line includes the XVIVO System (XPS), an integrated, ready-to-use cardiac bypass system designed to facilitate safe normothermic ex vivo lung perfusion (EVLP). To support this, the XPS Disposable Lung Kit offers all the necessary sterile, pre-packed components for EVLP procedures. Xvivo also provides STEEN Solution, an optimally formulated buffered extracellular solution specifically for perfusing isolated donor lungs during EVLP. Additional offerings comprise Perfadex Plus, an extracellular, low-potassium, dextran-based electrolyte preservation solution, and the XVIVO Silicone Tubing Set, used for efficient flushing of donor lungs during the procurement process. The company also manufactures the XVIVO LS and XVIVO Disposable Lung Set, both critical devices for EVLP. Furthermore, Xvivo provides the XVIVO Organ Chamber, a sterile, single-use disposable container for temporarily housing isolated lungs before transplantation, and the XVIVO Lung Cannula Set, another sterile, single-use disposable medical product. Established in 1998, Xvivo Perfusion AB (publ) is headquartered in Gothenburg, Sweden.
Precio por acción
$30.43
Última sincronización: 2026-08-28
Capitalización bursátil
$958.38M
Cambio (1 día)
-3.95%
Cambio (1 año)
71.66%
País
SE
Comercio Xvivo Perfusion AB (publ) (XVIVO)

Categoría

Precio XVIVO con Capital del mercado a B
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
XVIVO
$30.43
Capitalización de mercado de Xvivo Perfusion AB (publ)(XVIVO)
Capitalización bursátil: $958.38M
A fecha de August 2026, Xvivo Perfusion AB (publ) tiene una capitalización de mercado de $958.38M. Esto convierte a Xvivo Perfusion AB (publ) en la 9727th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Xvivo Perfusion AB (publ) desde 2012 hasta 2026
XVIVO en comparación con los más populares 5 títulos stocks
Precio por XVIVO Activo B Capital del mercado en B Resultados
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
$167,110 $958.38M
$5.264T +549,145.58%
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
$149,249 $958.38M
$4.701T +490,443.29%
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
$132,611 $958.38M
$4.177T +435,757.53%
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
$121,189 $958.38M
$3.817T +398,217.51%
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
$90,996.35 $958.38M
$2.866T +298,981.00%